[ RECIPIENT ENTITY RECORD ]

Carmot Therapeutics

VERIFIED NODE ID: 001877 · carmot-therapeutics-2
R TARGET NODE — CAPITAL RECIPIENT
Carmot Therapeutics
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Carmot Therapeutics
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Carmot Therapeutics is a biotechnology company focused on discovering innovative therapies for metabolic diseases such as obesity and type 2 diabetes. Based in California, the firm utilizes a proprietary discovery platform to identify novel drug candidates. It was a significant destination for institutional healthcare capital through its recent acquisition.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $2.7B